MannKind Corporation Stock News

MannKind Co. (NASDAQ:MNKD) – Equities researchers at SVB Leerink upped their FY2020 earnings estimates for MannKind in a report issued on Wednesday, July 29th. SVB Leerink analyst T. Smith now forec

WESTLAKE VILLAGE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 second quarter financial results and its management will host a conference call to

MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WESTLAKE VILLAGE, Calif., July 20, 2020 -- MannKind Corporation (NASDAQ: MNKD) today announced that effective August 4, 2020, Alejandro Galindo, M.B.A, M.S., will be leading.

MannKind (NASDAQ:MNKD)‘s stock had its “buy” rating reiterated by equities research analysts at Oppenheimer in a report issued on Tuesday, AnalystRatings.com reports. They presently have a $2.50

Brokerages expect MannKind Co. (NASDAQ:MNKD) to report earnings per share (EPS) of ($0.05) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for MannKind’s earnin

MannKind (NASDAQ:MNKD) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Mannkind

We will have to wait to see if the wind is truly changing to the bears, or if the bulls can come back throughout the day – either way, our deep learning algorithms paired with Artificial Intelligenc

Analysts expect MannKind Co. (NASDAQ:MNKD) to post sales of $15.43 million for the current quarter, according to Zacks. Three analysts have made estimates for MannKind’s earnings, with the lowest sa

MannKind Corporation (NASDAQ:MNKD) Lytham Partners Virtual Investor Growth Conference June 24, 2020 12:00 PM ET Company Participants Michael Castagna - CEO Conf

Single-product dependence and a high valuation could present serious risks for MNKD stockholders

Shares of MannKind Co. (NASDAQ:MNKD) traded up 11.7% on Monday . The company traded as high as $1.95 and last traded at $2.16, 274,007 shares changed hands during trading. A decline of 92% from the av

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) ACADIA Pharmaceuticals Inc...

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) ADC Therapeutics SA (...